dr. ferris on significance of checkmate-141 trial for head and neck cancer
Published 8 years ago • 215 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
2:25
dr. ferris on checkmate-141 trial in head and neck cancer
-
1:36
dr. ferris on potential of nivolumab in head and neck cancer
-
2:01
dr. ferris on the checkmate-041 trial for head and neck cancer
-
0:39
barbara burtness, md on whether the checkmate-141 study will accelerate the use of pd-l1 testing
-
1:58
dr. plimack on significance of checkmate-025 trial in rcc
-
1:36
dr. seiwert on prognosis for patients with head and neck cancer
-
6:51
pembrolizumab and nivolumab in recurrent hnscc
-
1:14
dr. choueiri on significance of checkmate-025 study for rcc
-
4:24
historic perspective on recurrent hnscc
-
1:58
dr. vokes on nivolumab, pembrolizumab approvals in head and neck cancer
-
2:13
nivolumab in hnscc
-
6:13
checkmate-227: testing ipilimumab/nivolumab in nsclc
-
1:08
dr. califano on the role of multidisciplinary care for head and neck cancer
-
1:06
dr. cohen discusses the keynote-040 trial in head and neck cancer
-
11:57
immunotherapy in hnscc
-
8:06
ongoing research of immunotherapy in hnscc
-
1:18
combinations with radiation for head and neck cancer
-
5:14
immunotherapy for recurrent hnscc
-
7:13
nivolumab confers better os in patients with metastatic squamous cell carcinoma of the head and neck